Statement Of Cash Flows [Abstract]

GenSight Biologics S.A. - Filing #832858

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
3,689,000 EUR
120,000 EUR
Cash flows from (used in) operations before changes in working capital
27,118,000 EUR
29,837,000 EUR
Increase (decrease) in working capital
2,454,000 EUR
3,916,000 EUR
Adjustments for increase (decrease) in other liabilities
3,197,000 EUR
3,240,000 EUR
Adjustments for increase (decrease) in employee benefit liabilities
25,000 EUR
30,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of warrants
60,000 EUR
37,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.